You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tetrathiomolybdate

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • Tetrathiomolybdate
  • +2 more
  • (no location specified)
Nov 15, 2023

Healthy Trial in Lincoln (ALXN1840 Enteric-coated Tablet, ALXN1840 Non-coated Capsule, Omeprazole)

Completed
  • Healthy
  • ALXN1840 Enteric-coated Tablet
  • +2 more
  • Lincoln, Nebraska
    Clinical Trial Site
Apr 1, 2022

Healthy Trial in London (ALXN1840)

Completed
  • Healthy
  • London, United Kingdom
    Clinical Trial Site
Apr 1, 2022

Healthy Trial in Lincoln (ALXN1840, Omeprazole)

Completed
  • Healthy
  • Lincoln, Nebraska
    Clinical Trial Site
Apr 1, 2022

Wilson Disease Trial in Worldwide (Bis-Choline Tetrathiomolybdate)

Active, not recruiting
  • Wilson Disease
  • Bis-Choline Tetrathiomolybdate
  • Sacramento, California
  • +10 more
Jan 26, 2023

Wilson Disease Trial in Austin (ALXN1840, Celecoxib)

Completed
  • Wilson Disease
  • Austin, Texas
    Clinical Trial Site
Nov 2, 2021

Wilson Disease Trial in Austin (ALXN1840, Bupropion Hydrochloride)

Completed
  • Wilson Disease
  • Austin, Texas
    Clinical Trial Site
Jul 21, 2021

Healthy Trial in Austin (ALXN1840, Placebo, Moxifloxacin)

Unknown status
  • Healthy
  • Austin, Texas
    Clinical Research Site
Feb 11, 2021

NSCLC Trial in Rochester (Tetrathiomolybdate)

Completed
  • Non-Small Cell Lung Cancer
  • Tetrathiomolybdate
  • Rochester, New York
    University of Rochester
Jul 17, 2019

Wilson Disease Trial (ALXN1840)

Available
  • Wilson Disease
  • (no location specified)
Jan 6, 2023

Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)

Recruiting
  • Fibrotic Pulmonary Sequelae Post-COVID19 Infection
  • Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Dec 29, 2021

Wilson Disease Trial in New Haven (Once a day Trientine)

Completed
Has Results
  • Wilson Disease
  • Once a day Trientine
  • New Haven, Connecticut
    Yale University
Apr 1, 2020

Wilson Disease Trial in Worldwide (ALXN1840)

Completed
Has Results
  • Wilson Disease
  • Los Angeles, California
  • +8 more
Sep 28, 2021

Primary Biliary Cirrhosis Trial in Ann Arbor (Tetrathiomolybdate, Placebo)

Completed
  • Primary Biliary Cirrhosis
  • Tetrathiomolybdate
  • Placebo
  • Ann Arbor, Michigan
    University of Michigan
May 19, 2017

Esophageal Carcinoma Trial in Ann Arbor (Tetrathiomolybdate (TM), Radiation, Surgery)

Completed
Has Results
  • Esophageal Carcinoma
  • Tetrathiomolybdate (TM)
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Jul 12, 2016

Psoriasis Trial in Ann Arbor (Tetrathiomolybdate (TM))

Completed
  • Psoriasis
  • Tetrathiomolybdate (TM)
  • Ann Arbor, Michigan
    University of Michigan Department of Dermatology
May 20, 2015

Prostate Cancer Trial in Ann Arbor (Tetrathiomolybdate)

Completed
  • Prostate Cancer
  • Tetrathiomolybdate
  • Ann Arbor, Michigan
    The University of Michigan Comprehensive Cancer Center
Jan 20, 2015

Idiopathic Pulmonary Fibrosis Trial in Ann Arbor (Tetrathiomolybdate)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Tetrathiomolybdate
  • Ann Arbor, Michigan
    University of Michigan Health System
Feb 5, 2013

Breast Cancer Trial in Oxford (drug, genetic, other)

Terminated
  • Breast Cancer
  • SOD1 inhibitor ATN-224
  • +5 more
  • Oxford, England, United Kingdom
    Cancer Research UK Medical Oncology Unit at Churchill Hospital &
Jul 9, 2013

Lung Cancer Trial in Buffalo (drug, other, radiation)

Withdrawn
  • Lung Cancer
  • ammonium tetrathiomolybdate
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 8, 2012

Colorectal Carcinoma Trial in Ann Arbor (Irinotecan, 5-Fluorouracil, Leucovorin)

Completed
  • Colorectal Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
Feb 5, 2012

Multiple Myeloma Trial in United States (ATN-224 + bortezomib)

Terminated
  • Multiple Myeloma
  • ATN-224 + bortezomib
  • Fresno, California
  • +9 more
Oct 27, 2008

Prostate Cancer Trial in United States (ATN-224)

Unknown status
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Jan 28, 2008

Melanoma Trial in United States (ATN-224, Temozolomide)

Unknown status
  • Melanoma
  • Tucson, Arizona
  • +16 more
Dec 4, 2007

Wilson Disease Trial in Ann Arbor (tetrathiomolybdate, trientine)

Completed
  • Wilson Disease
  • Ann Arbor, Michigan
    University of Michigan
May 8, 2006